Carsten Ehrhardt is Professor of Pharmaceutics and Biopharmaceutics and Director of Global Engagement at the School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin. He was elected Fellow of Trinity College Dublin (2013) and, in 2025, of both the International Society for Aerosols in Medicine and the American Association of Pharmaceutical Scientists. His research focuses on drug disposition and transport in the lungs, using advanced in vitro and ex vivo models, with additional interests in the molecular basis of airway diseases and antimicrobial therapies for lung infections. Carsten has authored 118 peer-reviewed publications and one edited book. He serves as Associate Editor of Journal of Aerosol Medicine and Pulmonary Drug Delivery and Section Editor of European Journal of Pharmaceutical Sciences, and sits on the editorial advisory boards of European Journal of Pharmaceutics and Biopharmaceutics, Pharmaceutics, and Pharmaceutical Research. He is also a member of the inhalation-based Biopharmaceutics Classification System (iBCS) initiative and founded the PDD Workshop series in 2013, now held annually in Dublin and Istanbul.
Prof. Carsten Ehrhardt
Funded Lead Investigators | TRP021; Lead PI
TCD
carsten.ehrhardt@tcd.ie
Carsten Ehrhardt is Professor of Pharmaceutics and Biopharmaceutics and Director of Global Engagement at the School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin. He was elected Fellow of Trinity College Dublin (2013) and, in 2025, of both the International Society for Aerosols in Medicine and the American Association of Pharmaceutical Scientists. His research focuses […]
Last Updated:
Research Areas:
Research Programmes
Related News

Innovation Training for ARC Hub for Therapeutics Translational Researchers
To complement excellence in scientific research, successful commercialisation requires research teams to have a strong understanding of their target markets, the specific problems their technologies address, the competitive landscape, and the ability to...

New €31.6 million ARC Hub for Therapeutics to turn breakthrough Irish research into therapies and companies
On December 3rd, 2025, we marked a major milestone for Ireland’s therapeutics ecosystem. The launch of the ARC Hub for Therapeutics was an energising and inspiring day, bringing together a brilliant community of academics, investors, funders, policymakers, and...
